Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Clinical trial NCT04849351 · COMPLETED
Trial details
- NCT number
- NCT04849351
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-15
- Primary completion
- 2024-02-29
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.